The nucleotide sequence of the region containing the promoter-operator for the aroP gene was determihed. The start site of aroP transcription was identified by using Si nuclease mapping and primer extension techniques. Examination of the nucleotide sequence revealed the presence of two "TYR R" boxes which are similar to those identified in the regulatory regions of other genes in the tyrR regulon. Bisulfite-induced aroP operator-constitutive mutants were analyzed, and the base-pair changes responsible for alterations in aroP regulation were located within these boxes.
Previous studies have shown that transport of the aromatic amino acids phenylalanine, tyrosine, and tryptophan is carried out in Escherichia coli K-12 and Salbtonella typhimurium by a general transport system (2, 6, 11) or by systems specific for each of the three amino acids (2, 6) . Mutants deficient in the general aromatic amino acid transport system have been isolated, and their mutations have been mapped at the aroP locus, at minute 3 on the E. coli chromosome (6) . The aroP gene has been cloned, and its product has been shown to be a protein associated with the cytoplasmic membrane (12) . Whipp and Pittard (35) showed that the general aromatic amino acid transport system involving the aroP product is subject to repression control by the TyrR protein acting in conjunction with phenylalanine, tyrosine, or trypttphan. In addition to regulating its own expression, the TyrR protein also regulates the expression of genes involved in tyrosine-specific transport, tryptopharispecific transport, and aromatic biosynthesis (7-9, 17, 21, 23, 32, 34) . These genes together constitute the tyrR fegulon. Nucleotide sequence analysis of the regulatory regions of some of these genes (13, 14, 16, 18, 20, 22) has allowed the identification of putative operator loci which contain variations of a consensus sequence referred to as the "TYR R" box (16) . Operator mutants have been sequenced in the cases of aroF (18) and tyrP (22) . In each case the, mutations have been located within the TYR R boxes.
In this paper we describe the construction of aroP-lac and aroP-cat fusions in which the level of aroP transcription can be readily measured, the cloning and sequencing of the aroP promoter-operator region, and the isolation and sequencing of aroP operator-constitutive mutants.
MATERIALS AND METHOIDS
Bacterial strains, plasmids, and bacteriophages. The bacterial strains used were all derivatives of E. coli K-12 and, along with the plasmids used in this study, are described in Table 1 . The bacteriophages Mu dl(Ap lac), X pl(209), M13mp8, and M13mp9 have been described previously (10, 11, 26) . The promoter-cloning vectors pkk232.8 and pMU530
have also been described (5, 22) .
Cheiicals and media. The chemicals used were obtained commercially and were not further purified. L-[U-14C]tyrosire (500 mCilmmol), [t-32P]dATP (-2,000 to 3,000 * Corresponding author.
Ci/mmol; 10 mCi/ml), [a-32P]dCTP (-2,000 to 3,000 Ci/mmol; 10 mCi/ml) and [a-35S]dATP (1,220 Ci/mmol; 7.9 mCi/ml) were purchased from Amersham Corp.
The minimal medium used was half-strength medium 56 (29) supplemented with appropriate growth requirements. To study repression, minimal medium Was supplemented with aromatic amino acids at the following concentrations:
L-phenylalanine, 10-3 M; L-tyrosifne, 10-3 M; and Ltryptophan, 5 x 10' M.
Antibiotics were used at the following finai concentrations (micrograms per milliliter): ampicillin, 25; chloramphenicol, 25; kanamycin, 20; tetracycline, 5 in minimal mediumn and 15 in nutrient mediumn; and trimethoprim, 10 in minimal medium and 40 in nutrient medium. 5-Bromo-4-chloro-3-indolyt-,B-galactopyranoside (X-Gal) was used at a final concefltration of 25 ,ug/ml.
Transport and enzyme assays. The assays for tyrosine transport, 3-galactosidase, and chloramphenicol acetyltransferase were carried out as previously described (22, 28, 33, 35) .
Nuclease S1 mapping. The 5' ends of in vivo transcripts were mapped by the nuclease S1 procedtre, with RNA prepared from mid-log-phase cells (1, 4) . Derivatives of M13mp8 were used to prepare single-stranded [a-32P]dATPlabeled probes by methods previously described (22) . Probe 1 was prepared from an mp8 derivative containing a 599-base-pair (bp) BglII-BamHI fragment from pMU1409 cloned into the BamHI site of mp8. Probe 1 included nucleotides 1 to 585 of the sequence of the aroP regulatory region (see Fig.  4 ). Probe 2 was prepared from an mp8 containing a 568-bp BglII-HincII insert and includes nucleotides 1 to 555 of the aroP sequence (see Fig. 4 ). The individual steps in the S1 mapping were as described before (22) .
Primer extension technique. The 5' end of in vivo transcripts was also mapped by using the primer extension technique described by Hudson and Davidson (20) . A 120-base SfaNI single-stranded DNA primer was generated from the M13rnp8 clone used in the preparation of probe 1. In this case [o-35S]dATP was used as a label, and following de novo synthesis the enzyme SfaNI was used fot digestion. This SfaNI site lies downstream from the start site of aroP transcription (see Fig. 4 ). After digestion the DNA was denatured at 95°C in 100% formamide. The single strands were separated in a 6% sequencing gel, and the singlestranded DNA probe was purified as described previously (22) . After hybridization to mRNA from JP3561(pMU1409), a The units of ,B-galactosidase specific activity are those described by Miller (28) . Growth occurred in minimal medium only (MM) or in MM supplemented with 10-3 M phenylalanine (MMP), 5 x 1o-4 M tryptophan (MMT), or both of these aromatic amino acids plus 10-3 M tyrosine (MMA).
the SfaNI primer was extended with reverse transcriptase. The product of extension was electrophoresed against the sequencing reactions of the identical mp8 clone used to generate the primer. Recombinant DNA techniques. Standard procedures were used essentially as described elsewhere (15, 26, 27) . Purification of the 1.7-kilobase (kb) HindIII restriction fragment from pMU516 was performed by the method of Langridge et al. (25) . Nucleotide sequences of cloned fragments were determined by the dideoxy nucleotide termination method of Sanger et al. (32) . In vitro mutagenesis with sodium bisulfite was based on the method of Peden and Nathans (30) (see 
RESULTS
Isolation of aroP-lac fusions. To clone the promoteroperator region of aroP, operon fusions were constructed between aroP and lacZ. Bacteriophage Mu dl(Ap lac) was used to lysogenize strain JP3060 (aroP+ aroG aroH), and putative aroP::Mu dl(Ap lac) clones were selected on medium containing ampicillin and 3-fluorotyrosine (2 x 10-6 M). Previous experiments had shown that aroP mutant derivatives of JP3060 but not JP3060 itself would grow on medium containing this level of analog (P. Kasian, unpublished results). A number of clones were purified, and their identity was confirmed by ,-galactosidase and transport assays. One of these clones (JP3744) was chosen for further study. With Xpl(209) and the method of Komedo and Iino (24) , A aroP-lac phage was isolated and used to lysogenize a A imm434 derivative of JP3060, designated JP3876, to form JP3877. Enzyme studies with JP3744, its tyrR derivative, and JP3877 establishing that P-galactosidase expression occurs from the aroP promoter in strains JP3744 and JP3877 are shown in Table 2 . Because these strains possessed only the tyrosine-inhibitable and -repressible 3-deoxy-D-arabinoheptulsonic acid 7-phosphate synthase enzyme, it was not possible to test the effect of tyrosine alone on Pgalactosidase expression. However, phenylalanine alone or the three aromatic amino acids together almost completely repress ,3-galactosidase expression in strains JP3744 and JP3877 but not in the tyrR derivative of JP3744 (Table 2) . Tryptophan causes about 50% inhibition in tyrR' cells. It is also worth noting that the level of 3-galactosidase expression in tyrR+ cells grown in minimal medium is about the same as that observed in the tyrR mutant. Control by tyrR is therefore only evident when the aromatic amino acids are added to the medium. These results are in agreement with previous studies on the control of aroP expression involving measurement of tyrosine transport (35) and establish that the TyrRmediated control of aroP occurs at the level of transcription. Kasian, personal communication) and a diagrammatic representation of the transfer of the chromosomal aroP-lac fusion from JP3877 to this plasmid by in vivo recombination, via lac and A homologies, to form pMU516. pMU512 carries a 14.5-kb BglIl-PstI insert in a low-copy-number IncW-derived Tpr vector, pREG151 (22) . The construction of pMU512 was carried out in a series of steps (data not shown), but essentially the 14.5-kb insert consists of DNA derived from X pl(209) (10) . The pREG151-derived region is denoted by solid bars, the trp'BA'-lac'ZYA' region by cross-hatched bars and X DNA by open bars. The event of crossing-over can occur within the region of X DNA (-6 kb) located upstream from the aroP promoter and in the trp'BA'-1ac'ZYA' region (-5 kb; located downstream from this promoter) which are homologous in pMU512 and the X paroP-lac fusion. pMU516 has acquired each of a BamHI, HindlIl, and SmaI site from the aroP promoter region and a HindlIl site from the trp'CBA' region (11) , but has lost each of a PstI and HindIII site from the Mu c region. The X paroP-lac phage was not physically mapped, and therefore restriction sites on the X paroP-lac fusion in JP3877 are not shown. Abbreviations: B, BamHI; Bg, BgII; E, EcoRI; H, HindlIl; P, PstI; Sm, SmaI; X, XhoI; Tpr, trimethoprim resistance.
In vivo recombination was next used to transfer aroP-lac to the plasmid vector pMU512 as shown in Fig. 1 . DNA was extracted from cells of JP3877(pMU512) and used to transform the Lac-strain JP3561. Selection was made for trimethoprim-resistant clones, and their Lac phenotype was determined by including X-Gal in the medium. The plasmid (pMU516) contained in one of the Lac' clones was shown to cohtain a new 1.7-kb HindIlI fragment and to express ,-galactosidase from the aroP promoter. That is, in tyrR+ cells f-galactosidase synthesis was repressed by phenylalanine and tyrosine and to a lesser extent by tryptophan, whereas in tyrR mutant cells synthesis was constitutive (data not shown). Subcloning of this 1.7-kb HindlIl fragment to the low-copy-number promoter-cloning plasmid pMU530 (22) confirmed that the aroP promoter-operator region was contained in this fragment (Table 3) . Subsequent digestion of the purified 1.7-kb fragment with HaeIII retained this region on an 0.75-kb fragment (pMU1407; Fig. 2 ). Digestion with Bal 31 from the unique PstI site in pMU1407 produced plasmids with 0.6-and 0.45-kb inserts (pMU1408 and pMU1443, respectively). These constructions are summa- b In pMU516 the size of the insert is not known exactly but is greater than the 1.7-kb HindIII fragment. rized in Fig. 2 , and the results of the enzyme assays are presented in Table 3 . Two aspects of these results require special comment. First, regulation of P-galactosidase expression by the aromatic amino acids is retained in all constructs except for pMU1443, in which the insert has been reduced to 0.45 kb. The major feature of this control is the very strong repressing effect of either tyrosine or phenylalanine, which contrasts with the reproducible but less severe effect of tryptophan previously reported in Table 2 . Second, the level of 3-galactosidase expression under repressing conditions was not constant in the various constructs. The most likely explanation for this relates to a deficiency in the promoter cloning vector pMU530. This vector does not possess terminator sequences to prevent transcriptional readthrough from promoters upstream of the cloning site. When the aroP promoter-operator region present on pMU1408 was subsequently introduced into the promotercloning vector of Brosius (5) (see below), full repression by the aromatic amino acids was observed, confirming our conclusion that this region is retained intact on pMU1408.
Nucleotide sequence determination of the aroP regulatory region. The strategy used for determining the nucleotide sequence of the aroP operator-promoter region is summarized in Fig. 3 . To derive plasmids with shortened versions of the insert in pMU1408, a 1.4-kb Sall fragment encoding kanamycin resistance was first cloned into the XhoI site of pMU1408 to make pMU1409. This plasmid was then linearized at the BglII site and digested with Bal31. After Bal31 digestion, BamHI linkers were added and the molecules were religated. These were then cloned into M13mp8 and M13mp9 (Fig. 3) and used to determine the nucleotide sequence of the 585-bp region containing the aroP promoteroperator region.
This sequence (Fig. 4) was analyzed for the presence of putative promoters, TYR R boxes, and the Shine-Dalgarno sequence by using the TRLTIN computer program (13) though a double TYR R box was readily identified, no sequences corresponding to putative -10 or -35 promoter bp regions could be found closer than 41 bases from the putatiVe 300 400 500 600 operator. A strong Shine-Dalgarno sequence could also be identified with a potential ATG initiation codon within 5 to 9 bases (Fig. 4) . Identification of the start site of aroP transcription. The Bhe DNA sequencing runs. The quence and will hybridize to mRNA generated from art of the clone whieh was not pMU1409, we mapped the start site of aroP transcription ich each clone starts on the between positions 442 and 433 (Fig. 4) .
rresponding nucleotide number
The primer extension method was used to map the start Fig. 4 Fig. 6 show that the 5' end of the aroP transcript was located at nucleotide 423 of the sequence shown in Fig.  4 .
Isolation of operator mutants. To isolate operator mutants, an aroP-cat fusion plasmid was constructed by using the promoter-detecting plasmid pkk232.8 (5) 6 . Determination of the start site of AroP transcription by primer extension. A 120-bp SfaNI 35S-labeled probe was used as primer (band P), and the product of extension (band E) with this primer corresponded to the encircled T nucleotide on the sequenc-. ing ladder of the sense strand of the aroP regulatory region. A, C, G, and T are the various residues from the dideoxynucleotide sequencing reactions obtained when the identical mp8 clone used to generate the primer was sequenced. Lanes: 1, Unextended primer (P); 2, product of extension (E).
enabled us to develop a strategy for the isolation of operatorconstitutive aroP mutants by using plasmid pMU1631 in strains with pMU1065.
To facilitate the isolation of operator mutants, plasmids pMU1631 and pkk232.8 were linearized with HindIII and PvuII, respectively, denatured, mixed, and reannealed to form heteroduplexes and mutagenized with sodium bisulfite ( Fig. 7) (30) . After mutagenesis the DNA was used to transform the ung mutant strain BW310(pMU1065) selecting on glucose minimal medium containing chloramphenicol (25 ,ug/ml), ampicillin, and kanamycin and repressing concentrations of one or all of phenylalanine, tyrosine, and tryptophan. A number of derepressed clones were obtained. That the phenotypic changes were due to lesions occurring within the aroP regulatory region was confirmed by recloning the 0.3-kb SmaI-BamHI fragment from each clone into pkk232.8 and checking the phenotype. The same fragments were also cloned into M13mp8 and M13mp9 for DNA sequencing.
The single-base changes in the nucleotide sequence of each of the mutant plasmids are shown in Fig. 4 . These base changes were either C--T or G-+A transitions, as would be expected with bisulfite mutagenesis. The base changes occurring in each of these plasmids were found to be located in one or the other of the two palindromic arms of the first TYR R box (Fig. 4) . Three of the mutant plasmids, pMU1674, pMU1676, and pMU1677, involved a cA transition occurring in the left arm of the first TYR R box, and a fourth, pMU1678, involved a T-*T trahsition in the right arm of the same box.
Chloramphenicol acetyltransferase assays carried out on two of the plasmid-bearing strains, BW310(pMU1065, pMU1678) and BW310(pMU1065, pMU1676), showed that partial constitutivity of aroP expression occurred in the presence of the three aromatic amino acids (Table 4 ). In these mutants the ability of tryptophan or phenylalanine to affect repression was greatly diminished. Tyrosine on the other hand continued to be a fairly effective co-repressor.
Also shown in Fig. 4 are the mutations present on a plasmid, pMU1663, which was isolated after longer treatment with bisulfite. There are mutations in this plasmid in both TYR R boxes, as well as a number outside the TYR R box region. Repression in strains carrying this klasmid by (18) . The consensus for the TYR R box is given; capital letters indicate the common bases of at least 9 of 12 boxes of genes within the tyrR regulon while lower-case letters denote those common to at least 6 boxes. Nucleotide changes in various operator constitutive mutants are marked by arrows. The arrow accompanied with an asterisk (*) marks the G--A substitution in the second TYR R box which was only found on pMU1663. The -35 and -10 regions are overlined. Symmetrical sequences are underlined.
any or all of the three amino acids was completely abolished (Table 4) .
DISCUSSION
The regulatory role of the TyrR protein acting in conjunction with any of the three aromatic amino acids to repress transport by the general aromatic system as had been observed in an earlier study (35) was confirmed in the present study and was shown to occur at the level of transcription of the gene aroP.
An examination of the nucleotide sequence of the fragment containing the wild-type aroP operator locus revealed the presence of two TYR R boxes. These boxes were later confirmed to be the repressor-binding site on the aroP regulatory region by the isolation and sequence analysis of aroP operator mutants. This observation supports the hypothesis that the TYR R box is indeed the operator site in each of the genes belonging to the tyrR regulon. Operator mutants have also been sequenced in aroF (18) and tyrP (22) , and these mutations have been located within TYR R boxes.
The TYR R boxes in aroP are imperfect palindromes, and although they each exhibit an identity of only 11/17 with the TYR R box consensus sequence (16; Fig. 8 ), they retain the as yet invariant GN14C arrangement in each box. Either one or the other of these critical bases has been altered in all single-base substitution operator mutants so far isolated in aroF (18) , one of two such mutants in tyrP (22) , and four such mutants in aroP (Fig. 8) . The operator mutants in aroF and tyrP were spontaneous mutants and were not isolated by using sodium bisulfite mutagenesis (which specifically affects C G base pairs only), yet these G and C bases on the right and left arms of the TYR R box have been altered. These two particular bases are apparently important and are likely to play a role in establishing contact with the TyrR protein.
The single-base mutations in the consensus palindromic arms of the TYR R boxes of aroP, tyrP (22) , and aroF (18) are shown in Fig. 8 . It was observed that base substitutions at corresponding sites in either arm of the TYR R box result in operator constitutivity of aroP and aroF.
It has previously been observed that the genes of the tyrR regulon which are repressed by the TyrR protein in the presence of tyrosine (aroF, aroL, and trP) have two adjacent TYR R boxes separated by a single A residue (22) . The analysis of aroP adds a further confirmation to this observation. The two unique mutant types obtained in the present study contained single-base substitutions in the first TYR R box which brought about major effects on tryptophan-and phenylalanine-mediated repression but only reduced tyrosine-mediated repression by 20%, suggesting that the first TYR R box in aroP is involved in tryptophan-and phenylalanine-mediated repression. The only strain in which tyrosine-mediated repression was completely abolished had multiple mutations, one in each of the two TYR R boxes and a number of others both upstream and downstream from the regulatory region. We are currently investigating whether a single mutation in the second box will abolish tyrosine repression or whether multiple mutations are required. In the case of each of two tyrR operator mutants, however, mutations in a single base located in the right-hand TYR R box (Fig. 8) resulted in complete loss of tyrosine repression (22) .
The location of the aroP operator site some 31-bp downstream from the transcription start site was unexpected. However, the use of both Si mapping and primer extension methods to determine the transcription start site confirms this observation. In the case of other genes of the tyrR regulon, the TYR R boxes in tyrP, aroF, aroG, and tyrR are located upstream from or around the -35 region. In aroL, a TYR R box lies around the -35 region, while two other such boxes are situated downstream from the -10 hexamer (16 
